29 December 2020

Recall,Lifting Suspension and Safety updates of a Pharmaceutical Product

Reference: CIR-2020-00000311

To all health care facilities and all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA would like to notify all health care facilities and practitioners regarding the Circular issued by MOHAP for information and adherance to what is stated

- Voluntary Recall from manufacturer for two lots of Medical product NP Thyroid 15 & NP Thyroid120

-  Lifting the Recall of four pharmaceutical products Cinfaval, Co-Cinfaval, Vanguard, Vanguard Plus

- Recall Counterfeit Product Rise 2.0 liquid Cialis 30ml bottle

- Medical device recall Trevo XP ProVue Retriever

 - Fluoroquínolones for systemic and inhalation formulations - Heart valve regurgitation, cervical artery dissection, and aortic aneurysm and dissection

- Pharmaceutical product recall & warning Depo-Medrol (methylprednisolone acetate) 40mgml 2ml disposable syringe

 

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

NP Thyroid 15 _ NP Thyroid120.pdf:

View Document

lifting the recall of four pharmaceutical products Cinfaval, Co-Cinfaval, Vanguard, Vanguard Plus.pdf:

View Document

Rise 2.0 liquid Cialis 30ml bottle.pdf:

View Document

Trevo XP ProVue Retriever.pdf:

View Document

Fluoroquínolones for systemic and inhalation formulations - Heart valve regurgitation, cervical artery dissection, and aortic aneurysm and dissection.pdf:

View Document

Pharmaceutical product recall _ warning Depo-Medrol (methylprednisolone acetate) 40mgml 2ml disposable syringe.pdf:

View Document